SAN DIEGO, Sept. 29, 2022 /PRNewswire/ — Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that Dr. Ingrid Delaet will join the company’s executive management team as Chief Regulatory Officer effective October 1, leading the regulatory affairs, quality assurance, medical…